Literature DB >> 18273732

Acquired left ventricular noncompaction as a cardiac manifestation of neuromuscular disorders.

Josef Finsterer1, Claudia Stöllberger, Bernd Schubert.   

Abstract

OBJECTIVES: In single cases left-ventricular-hypertrabeculation/noncompaction (LVHT) develops after birth (acquired-LVHT). This study aimed to determine the prevalence of acquired-LVHT, to look for echocardiographic similarities between acquired-LVHT cases, to determine the interval between the last normal echocardiography and detection of acquired-LVHT, and which neuromuscular-disorders are associated with acquired-LVHT.
DESIGN: We retrospectively looked for acquired-LVHT among a cohort of 22 LVHT-patients, diagnosed during 3 years. We compared cardiac and extra-cardiac findings between patients with acquired-LVHT.
RESULTS: Among the 22 patients with LVHT, acquired-LVHT was found in four of them. One of the four was echocardiographically normal when investigated before the detection of LVHT. At diagnosis of LVHT echocardiography showed cardiac abnormalities in addition to LVHT in three of the four patients. The last echocardiography without LVHT was carried out on the average 3.8 y before LVHT was detected. Two patients had a dystrophinopathy and two patients a metabolic myopathy.
CONCLUSION: Acquired-LVHT is more frequent than previously thought, requires review of previous echocardiographies, is largely associated with other cardiac abnormalities, and occurs most frequently together with neuromuscular-disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18273732     DOI: 10.1080/14017430701744451

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  18 in total

1.  Response to Letter by Finsterer and Zarrouk.

Authors:  Teck Wah Ting; Saumya Shekhar Jamuar
Journal:  Pediatr Cardiol       Date:  2015-08-14       Impact factor: 1.655

2.  Consider a Nongenetic Pathogenesis of Noncompaction.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Pediatr Cardiol       Date:  2015-08-13       Impact factor: 1.655

3.  Is mitochondrial disease the common cause of histiocytoid cardiomyopathy and non-compaction?

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Int J Legal Med       Date:  2008-10-10       Impact factor: 2.686

4.  Consider a mitochondrial disorder when left ventricular hypertrabeculation/noncompaction is associated with renal cysts.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Tex Heart Inst J       Date:  2014-12-01

5.  Noncompaction in mitochondrial trifunctional protein deficiency due to a HADHB mutation.

Authors:  Josef Finsterer; Sinda Zarrouk-Majoub
Journal:  Eur J Pediatr       Date:  2015-07-24       Impact factor: 3.183

Review 6.  Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors.

Authors:  Josef Finsterer; Claudia Stöllberger; Jeffrey A Towbin
Journal:  Nat Rev Cardiol       Date:  2017-01-12       Impact factor: 32.419

7.  Familial Himalayan p wave and left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Marion Avanzini; Peter Siostrzonek; Peter Kühn; Walther-Benedikt Winkler; Josef Finsterer
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-11       Impact factor: 1.468

8.  Myopathy should determine the anesthetic management in left ventricular hypertrabeculation/noncompaction.

Authors:  J Finsterer; C Stöllberger
Journal:  Heart Lung Vessel       Date:  2014

9.  Sudden cardiac death in isolated right ventricular hypertrabeculation/noncompaction cardiomyopathy.

Authors:  Soad Bekheit; Boutros Karam; Farshid Daneshvar; Julie Zaidan; Rabih Tabet; Jonathan Spagnola; James Lafferty
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-09-12       Impact factor: 1.468

Review 10.  Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction.

Authors:  Josef Finsterer
Journal:  Pediatr Cardiol       Date:  2009-01-29       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.